Search

Your search keyword '"Goldgar, D"' showing total 90 results

Search Constraints

Start Over You searched for: Author "Goldgar, D" Remove constraint Author: "Goldgar, D" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
90 results on '"Goldgar, D"'

Search Results

1. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.

2. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

3. Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits

4. First international workshop of the ATM and Cancer Risk Group (4–5 December 2019)

6. An updated quantitative model to classify missense variants in the TP53 gene: A novel multifactorial strategy

7. Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)

8. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

9. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

10. Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation Results.

11. Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort.

12. Cancer risks associated with germline PALB2 pathogenic variants: An international study of 524 families.

13. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance

14. Differences in patient ascertainment affect the use of gene-specified ACMG/AMP phenotype-related variant classification criteria: Evidence for TP53

15. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

16. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

17. Assessing biases of information contained in pedigrees for the classification of BRCA-genetic variants: a study arising from the ENIGMA analytical working group

18. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

19. Genome-wide association study of germline variants and breast cancer-specific mortality

20. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

21. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

22. BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

23. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

24. 10-year performance of four models of breast cancer risk: a validation study.

25. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations

26. Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk

27. Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool

28. Shared heritability and functional enrichment across six solid cancers

29. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

30. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

31. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)

32. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

33. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

34. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

35. The BRCA2 c.68‐7T > A variant is not pathogenic:a model for clinical calibration of spliceogenicity

36. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

37. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

38. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

39. Abstract P5-08-09: Use of oral contraceptives and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: An international prospective cohort study; for the studies of EMBRACE, GENEPSO, HEBON, kConFab and BCFR

40. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

41. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

42. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

43. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

44. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

45. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

46. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

47. Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

48. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

49. Assessing biases of information contained in pedigrees for the classification of BRCAgenetic variants: a study arising from the ENIGMA analytical working group.

50. Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG/AMP guidelines.

Catalog

Books, media, physical & digital resources